Why is stopping something in medicine so much harder than starting something new?

How do you tell an equity story when the exit doesn’t exist yet?

And what goes into deliberately building a career towards leadership so that every role is a stepping stone?

Today we’re speaking with Torbjørn Furuseth, CEO of DoMore Diagnostics based in Oslo, Norway. DoMore Diagnostics is personalising cancer treatment by analysing tumour tissue with AI algorithms.

Of course, we’ll talk more about the science at the end of the episode.

About LifeScience ORG

It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.

The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.

Chapters

1:12 - From Medicine to Leadership

2:52 - Natural Leadership Instincts

5:22 - Deliberate Career Planning

7:20 - Founding a Diagnostics Company

9:12 - Building High-Performing Teams

11:47 - Shared Startup Challenges

16:12 - Articulating the Equity Story

17:32 - Lessons from Downsizing

24:18 - AI in Cancer Diagnostics